Bleichroeder LP’s X4 Pharmaceuticals XFOR Stock Holding History

Bleichroeder LP’s Portfolio XFOR Stock Details XFOR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.78K	Hold	595	–	–	﹤0.01%	77
2026 Q1	$2.46K	Hold	595	–	–	﹤0.01%	79
2025 Q4	$2.38K	Hold	595	–	–	﹤0.01%	71
2025 Q3	$2.04K	Hold	595	–	–	﹤0.01%	71
2025 Q2	$1.13K	Sell	595 -1	-0.2%	-$4	﹤0.01%	76
2025 Q1	$4.22K	Hold	596	–	–	﹤0.01%	76
2024 Q4	$13.1K	Hold	596	–	–	﹤0.01%	71
2024 Q3	$12K	Hold	596	–	–	﹤0.01%	71
2024 Q2	$10.4K	Hold	596	–	–	﹤0.01%	71
2024 Q1	$24.8K	Hold	596	–	–	0.01%	70
2023 Q4	$15K	Hold	596	–	–	﹤0.01%	68
2023 Q3	$19.5K	Hold	596	–	–	﹤0.01%	61
2023 Q2	$34.7K	Sell	596 -595	-50%	-$30.6K	0.01%	66
2023 Q1	$31.1K	Hold	1,191	–	–	0.01%	65
2022 Q4	$35.5K	Hold	1,191	–	–	0.01%	64
2022 Q3	$61K	Hold	1,191	–	–	0.01%	67
2022 Q2	$34K	Hold	1,191	–	–	0.01%	80
2022 Q1	$63K	Hold	1,191	–	–	0.01%	97
2021 Q4	$82K	Hold	1,191	–	–	0.01%	91
2021 Q3	$189K	Hold	1,191	–	–	0.03%	75
2021 Q2	$232K	Hold	1,191	–	–	0.04%	71
2021 Q1	$308K	Hold	1,191	–	–	0.05%	58
2020 Q4	$230K	Hold	1,191	–	–	0.04%	52
2020 Q3	$242K	Hold	1,191	–	–	0.04%	55
2020 Q2	$333K	Hold	1,191	–	–	0.06%	52
2020 Q1	$357K	Hold	1,191	–	–	0.09%	47
2019 Q4	$382K	Buy	+1,191	New	+$427K	0.06%	37

Other funds holding XFOR

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

SVCM

Saturn V Capital Management Austin, Texas $697M AUM 628.57% 1-Year Est. Return

EAM

Empery Asset Management New York $86.5M AUM

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

KCM

Kalehua Capital Management Dallas, Texas $174M AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Bleichroeder LP's XFOR Position: Q2 2026 in Review

Bleichroeder LP held its X4 Pharmaceuticals (XFOR) position steady in Q2 2026 at 595 shares worth $2.78K. The position accounts for ﹤0.01% of the portfolio, ranked #77.

Bleichroeder LP first reported a position in XFOR in Q4 2019 and has held it in 27 quarters since. The position peaked at $382K in Q4 2019. 89 funds tracked by Wall St. Rank hold XFOR as of Q2 2026.

Bleichroeder LP held 595 shares of X4 Pharmaceuticals worth $2.78K as of Q2 2026.
Bleichroeder LP left its X4 Pharmaceuticals share count unchanged in Q2 2026.
X4 Pharmaceuticals made up ﹤0.01% of Bleichroeder LP's portfolio in Q2 2026, its #77 holding.
Bleichroeder LP first reported a position in X4 Pharmaceuticals in Q4 2019 and has held it in 27 quarters since.
Bleichroeder LP's X4 Pharmaceuticals position peaked at $382K in Q4 2019.
89 funds tracked by Wall St. Rank held X4 Pharmaceuticals as of Q2 2026.

Based on Bleichroeder LP's 13F filing for Q2 2026, filed 13 Aug 2026.